A statistical signalling model for use in surveillance of adverse drug reaction data

DOI10.1080/02664769823287zbMATH Open0934.62111OpenAlexW2030861700MaRDI QIDQ4266301FDOQ4266301

Authors: Eric M. Hillson, Charlotte A. McMillan, Jack H. Reeves 

Publication date: 27 April 2000

Published in: Journal of Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/02664769823287

Recommendations

• A likelihood ratio test based method for signal detection with application to FDA's drug safety data
• Active postmarketing drug surveillance for multiple adverse events
• Data mining of the Australian adverse drug reactions database: a comparison of Bayesian and other statistical indicators
• A study of speedier signal detection for serious adverse events
• Bayesian model selection in logistic regression for the detection of adverse drug reactions

zbMATH Keywords

surveillanceadverse drug events

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Software, source code, etc. for problems pertaining to statistics (62-04)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)

Cited In (4)

• Statistical modelling for risk assessment in pharmacoepidemiology: The case-crossover method.
• Title not available (Why is that?)
• Evaluations of some Exponentially Weighted Moving Average methods
• A fuzzy derivative approach to classification of outcomes from the ADRAC database

This page was built for publication: A statistical signalling model for use in surveillance of adverse drug reaction data

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4266301)